CD4 and neoplasm: An in vivo study also recently revealed that natural IgMs allow monocytes to present tumor neoantigens to CD4+ T cells leading to the emergence of activated T helper cells expressing CD40L with the capacity to license Ag-cross-presenting Batf3+ conventional type 1 DC for induction of a cytotoxic CD8+ T cell response [99].